Stock Groups

Mental health issues in kids rose during pandemic; awareness and use of COVID treatments is low -Breaking

[ad_1]

© Reuters. FILE PHOTOS: A group of children from Palestine participates in a session on mental health in Khan Younis, the south Gaza Strip. June 6, 2021. REUTERS/Ibraheem Abu Mustafa

Nancy Lapid

(Reuters) – The following summarizes recent research on COVID-19. These include additional research to confirm the findings, and which has not yet been certified by peer review.

Mental health problems in children and pandemics are linked

Researchers claim that the COVID-19 outbreak has adversely affected children and teens’ mental health, according to an analysis of 17 studies.

The studies – published in 2020 and 2021 – found unusually high rates of anxiety, depression, sleep disorders, suicidal behavior, stress-related disorders, attention-deficit/hyperactivity disorder, and other mental health problems during the pandemic. The studies found that positive mental health was associated with individual behaviors like praying and enjoying music. “Mental health problems were more common in those with low socioeconomic status, lack of social connections and support, adverse family relationships, restricted mobility,” among other factors including school closures and “COVID-related health experiences within family or community,” said Dr. M. Mahbub Hossain of Texas A&M University, who coauthored a report posted on Tuesday on medRxiv ahead of peer review.

Hossain explained that many schools and communities have made it impossible or difficult for adolescents and children to access mental health services. He added that there are multiple ways to address the social, health, and immediate consequences of the epidemic on mental health.

Low awareness and low use of anti-COVID medications

Survey results show that less than 2% nonhospitalized COVID-19 high-risk patients are being prescribed drugs to limit their disease.

In March 2022, researchers recruited 1,159 people from 37 states who were positive for SARS-CoV-2 on PCR tests and asked whether they knew about or had taken effective treatments for the virus, such as monoclonal antibodies or oral antiviral drugs molnupiravir from Merck & Co or Pfizer (NYSE:)’s Paxlovid. According to Tuesday’s medRxiv report, only 1.7% of the 241 people over 65 who are at high risk of severe COVID-19 were informed of treatment options and 36% had tried them.

Patients under the age of 65 were less likely to be aware of these treatments or have sought them. Rates of their use were also lower than those over the age of 65. To prevent death and serious diseases, the University of California at Los Angeles’ Dr. Noah Kojima said that the public needs to be more aware of COVID-19 treatments.

Omicron is seen in the airliner’s wastewater.

Tests of aircraft wastewater show that the requirement for proof of COVID vaccination or negative testing before taking off on international flights doesn’t necessarily prevent countries from spreading new variants.

Researchers discovered the Omicron variant in water from two commercial aircrafts which flew from Ethiopia in December 2021 to France. This was despite passengers being required to pass COVID screenings before they board and to show vaccination cards. According to Dr Bernard La Scola, a French study leader at Aix-Marseille University, “This could be explained by two factors.” First, long-distance travel can lead to negative tests the day before the departure but positive the moment you arrive. “The virus has not yet multiplied enough by the time the test is performed so that it’s detectable.” Fake documentation is also available. It was easy to get false-negative test results, according to some passengers.

He admitted that testing every passenger who returns from long-haul flights is difficult. His team proposed that the aircraft’s wastewater be tested as soon as it lands. This would allow for a quick and accurate result before any passengers go through baggage claim or customs. Passengers can have their wastewater tested prior to exiting if it is positive. However, this approach is only feasible in countries with a stable variant. La Scola stated that the virus is not useful if it circulates in a large number of countries.

For a Reuters graphic on vaccines in development: https://graphics.reuters.com/HEALTH-CORONAVIRUS/VACCINE-TRACKER/xegpbqnlovq/

[ad_2]